{
  "id": 9629546,
  "title": "Novel CAR-T therapy shows promising safety and durable responses in hard-to-treat multiple myeloma",
  "url": "https://urgent.news/2026/09/24/novel-car-t-therapy-shows-promising-safety-and-durable-responses-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T20:40:06.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-car-therapy-safety-durable-responses.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A phase 1 clinical trial led by investigators at Mass General Brigham Cancer Institute and the University of Chicago Medicine Comprehensive Cancer Center has found that an investigational CAR-T therapy can lead to deep and durable responses in people with relapsed or refractory multiple myeloma. Results are published in The New England Journal of Medicine.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}